PharVision Advisers’s Ares Commercial Real Estate ACRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26,066
Closed -$125K 104
2025
Q4
$125K Buy
+26,066
New +$127K 0.06% 638

Other funds holding ACRE

PharVision Advisers's ACRE Position: Q1 2026 in Review

PharVision Advisers sold out of Ares Commercial Real Estate (ACRE) in Q1 2026, closing a stake of 26,066 shares — an estimated $125K sold.

PharVision Advisers first reported a position in ACRE in Q4 2025 and held it in 1 quarter. The position peaked at $125K in Q4 2025. 138 funds tracked by Wall St. Rank hold ACRE as of Q1 2026.

  • PharVision Advisers reported no remaining Ares Commercial Real Estate position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 26,066 Ares Commercial Real Estate shares in Q1 2026, an estimated $125K.
  • PharVision Advisers first reported a position in Ares Commercial Real Estate in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Ares Commercial Real Estate position peaked at $125K in Q4 2025.
  • 138 funds tracked by Wall St. Rank held Ares Commercial Real Estate as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.